Report: Samsung to test genomic analysis service

Count Samsung as an interested player in the growing genomic analysis game. The Seoul-based tech giant's bioinformatics group plans to test a genomic analysis service, which will analyze whole genome sequencing and RNAseq data, Bio-IT World reports. A pilot phase of the service will take place from September to November, and researchers will be able to upload data onto the company's cloud to have it analyzed for free during the test period. It's more potential competition for a growing number of outfits--including BGI, Complete Genomics ($GNOM) and Knome--that are offering genomic analysis services. Report

Suggested Articles

There's no evidence personal patient information leaked during the 11-week breach, but the same can't be said about Sangamo's own secrets.

Through a new online tracker, AllTrials names sponsors who fail to report clinical trial results on time per the FDAAA Final Rule.

The new solution aims to streamline the incorporation of human genomic data into clinical trial designs.